DOI: 10.25881/BPNMSC.2020.60.73.019

Авторы

Шевченко Ю.Л., Стойко Ю.М., Гудымович В.Г., Черняго Т.Ю.

ФГБУ «Национальный медико-хирургический Центр имени Н.И. Пирогова» Минздрава России, Москва

Аннотация

Представлен обзор литературы по истории открытия и функции гликокаликса, который входит в состав мембраны эндотелиоцита. На основании проанализированных работ, которые были опубликованы в медицинской печати на протяжении последних 30 лет отмечена важность изучения функции и строения гликокаликса в эндотелиальном слое вен. Представлено значимое влияние гликокаликса в развитии патофизиологических процессов у пациентов с патологией сердечно-сосудистой системы.

Ключевые слова: гликокаликс, эндотелий, эндотелиальная дисфункция, сердечно-сосудистая система.

Список литературы

1. Шевченко Ю.Л., Стойко Ю.М., Гудымович В.Г. Дисфункция и повреждение эндотелия (патофизиология, диагностика, клинические проявления и лечение). — М.: Лика; 2015. — 166 с. [Shevchenko YuL, Stoyko YuM, Gudymovich VG. Disfunktsiya i povrezhdenie endoteliya (patofiziologiya, diagnostika, klinicheskie proyavleniya i lechenie). Moscow: Lika; 2015. 166 p. (In Russ).]

2. Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol. 1896;19(4):312–326. Doi: 10.1113/jphysiol.1896.sp000596.

3. Weinbaum S. 1997 Whitaker Distinguished Lecture: Models to solve mysteries in biomechanics at the cellular level; a new view of fiber matrix layers. Ann Biomed Eng. 1998;26(4):627–643. Doi: 10.1114/1.134.

4. Michel CC. Starling: the formulation of his hypothesis of microvascular fluid exchange and its significance after 100 years. Exp Physiol. 1997;82(1):1–30. Doi: 10.1113/expphysiol.1997.sp004000.

5. Bennett HS. Morphological aspects of extracellular polysaccharides. J Histochem Cytochem. 1963;11:14–23. Doi: 10.1177/11.1.14.

6. Hooke R. Micrographia — some physiological descriptions of minute bodies made by magnifying glasses with observations and inquiries thereupon. London: John Martin and James Allestry; 1665. Doi: 10.5962/bhl.title.904.

7. Rambourg A, Neutra M, Leblond CP. Presence of a “cell coat” rich in carbohydrate at the surface of cells in the rat. Anat Rec. 1966;154(1):41–71. Doi: 10.1002/ar.1091540105.

8. Vink H, Duling BR. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res. 1996;79(3):581-589. Doi: 10.1161/01.res.79.3.581.

9. Squire JM, Chew M, Nneji G, et al. Quasi-periodic substructure in the microvessel endothelial glycocalyx: a possible explanation for molecular filtering? J Struct Biol. 2001;136(3):239–255. Doi: 10.1006/jsbi.2002.4441.

10. Ainslie KM, Garanich JS, Dull RO, Tarbell JM. Vascular smooth muscle cell glycocalyx influences shear stress-mediated contractile response. J Appl Physiol (1985). 2005;98(1):242–249. Doi: 10.1152/japplphysiol.01006.2003.

11. Kang H, Liu M, Fan Y, Deng X. A potential gravity-sensing role of vascular smooth muscle cell glycocalyx in altered gravitational stimulation. Astrobiology. 2013;13(7):626–636. Doi: 10.1089/ast.2012.0944.

12. Ebong EE, Macaluso FP, Spray DC, et al. Imaging the endothelial glycocalyx in vitro by rapid freezing/freeze substitution transmission electron microscopy. Arterioscler Thromb Vasc Biol. 2011;31(8):1908–1915. Doi: 10.1161/ATVBAHA.111.225268.

13. van den Berg BM, Vink H, Spaan JA. The endothelial glycocalyx protects against myocardial edema. Circ Res. 2003;92(6):592–594. Doi: 10.1161/01.RES.0000065917.53950.75.

14. Горшков А.Ю., Бойцов С.А. Эндотелиальный гликокаликс — потенциальный сосудистый биомаркер: диагностическая и терапевтическая мишень сердечно-сосудистых заболеваний // Кардиоваскулярная терапия и профилактика. — 2015. — Т.14. — №6 — C. 87-92. [Gorshkov AYu, Boitsov SA. Endotelial'nyi glikokaliks — potentsial'nyi sosudistyi biomarker: diagnosticheskaya i terapevticheskaya mishen' serdechno-sosudistykh zabolevanii. Kardiovaskulyarnaya terapiya i profilaktika. 2015;14(6);87-92. (In Russ).]

15. van den Berg BM, Nieuwdorp M, Stroes ES, Vink H. Glycocalyx and endothelial (dys) function: from mice to men. Pharmacol Rep. 2006;58 Suppl:75–80.

16. Broekhuizen LN, Mooij HL, Kastelein JJ, et al. Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease. Curr Opin Lipidol. 2009;20(1):57–62. Doi: 10.1097/MOL.0b013e328321b587.

17. Rehm M, Zahler S, Lötsch M, et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology. 2004;100(5):1211–1223. Doi: 10.1097/00000542-200405000-00025.

18. Pahakis MY, Kosky JR, Dull RO, Tarbell JM. The role of endothelial glycocalyx components in mechanotransduction of fluid shear stress. Biochem Biophys Res Commun. 2007;355(1):228–233. Doi: 10.1016/j.bbrc.2007.01.137.

19. Nieuwdorp M, van Haeften TW, Gouverneur MC, et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes. 2006;55(2):480–486. Doi: 10.2337/diabetes.55.02.06.db05-1103.

20. Lopez-Quintero SV, Cancel LM, Pierides A, et al. High glucose attenuates shear-induced changes in endothelial hydraulic conductivity by degrading the glycocalyx. PLoS One. 2013;8(11):e78954. Doi: 10.1371/journal.pone.0078954.

21. Reyes-Soffer G, Holleran S, Di Tullio MR, et al. Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus. Metabolism. 2010;59(9):1365–1371. Doi: 10.1016/j.metabol.2009.12.023.

22. Mulivor AW, Lipowsky HH. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol. 2004;286(5):H1672–H1680. Doi: 10.1152/ajpheart.00832.2003.

23. Bruegger D, Rehm M, Jacob M, et al. Exogenous nitric oxide requires an endothelial glycocalyx to prevent postischemic coronary vascular leak in guinea pig hearts. Crit Care. 2008;12(3):R73. Doi: 10.1186/cc6913.

24. Chappell D, Jacob M, Hofmann-Kiefer K, et al. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology. 2007;107(5):776–784. Doi: 10.1097/01.anes.0000286984.39328.96.

25. Rehm M, Bruegger D, Christ F, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation. 2007;116(17):1896–1906. Doi: 10.1161/CIRCULATIONAHA.106.684852.

26. Bruegger D, Rehm M, Abicht J, et al. Shedding of the endothelial glycocalyx during cardiac surgery: on-pump versus off-pump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2009;138(6):1445–1447. Doi: 10.1016/j.jtcvs.2008.07.063.

27. Lewis JC, Taylor RG, Jones ND, et al. Endothelial surface characteristics in pigeon coronary artery atherosclerosis. I. Cellular alterations during the initial stages of dietary cholesterol challenge. Lab Invest. 1982;46(2):123–138.

28. Vink H, Constantinescu AA, Spaan JA. Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation. 2000;101(13):1500–1502. Doi: 10.1161/01.cir.101.13.1500.

29. van den Berg BM, Spaan JA, Rolf TM, Vink H. Atherogenic region and diet diminish glycocalyx dimension and increase intima-to-media ratios at murine carotid artery bifurcation. Am J Physiol Heart Circ Physiol. 2006;290(2):H915–H920. Doi:10.1152/ajpheart.00051.2005.

30. Marechal X, Favory R, Joulin O, et al. Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock. 2008;29(5):572–576. Doi: 10.1097/SHK.0b013e318157e926.

31. Kharabi Masouleh B, Ten Dam GB, Wild MK, et al. Role of the heparan sulfate proteoglycan syndecan-1 (CD138) in delayed-type hypersensitivity. J Immunol. 2009;182(8):4985–4993. Doi: 10.4049/jimmunol.0800574.

32. Ostrowski SR, Gaïni S, Pedersen C, Johansson PI. Sympathoadrenal activation and endothelial damage in patients with varying degrees of acute infectious disease: an observational study. J Crit Care. 2015;30(1):90–96. Doi:10.1016/ j.jcrc.2014.10.006.

33. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011;254(2):194–200.

34. Shirazi LF, Bissett J, Romeo F, Mehta JL. Role of inflammation in heart failure. Curr Atheroscler Rep. 2017;19(6):27. Doi: 10.1007/s11883-017-0660-3.